We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Delta Air Lines
DAL
$50.5B
| $77.9M | 0.15% |
1,979,982
-527,977
| -21% | -$20M |
2016 Q2
1 quarter
|
|
152
Eli Lilly
LLY
$1.15T
| $77.4M | 0.15% |
965,149
-85,752
| -8% | -$6.86M |
2016 Q2
1 quarter
|
|
153
Xcel Energy
XEL
$47.9B
| $77.4M | 0.15% |
1,882,408
+25
| +0% | +$1.07K |
2016 Q2
1 quarter
|
|
154
Bank of New York Mellon
BNY
$97.9B
| $77.1M | 0.15% |
1,933,671
-278,676
| -13% | -$11.1M |
2016 Q2
1 quarter
|
|
155
ICICI Bank
IBN
$107B
| $76.5M | 0.15% |
11,272,857
-6,590,995
| -37% | -$45.9M |
2016 Q2
1 quarter
|
|
156
Healthpeak Properties
DOC
$12.9B
| $75.7M | 0.15% |
2,190,775
-504,626
| -19% | -$17.7M |
2016 Q2
1 quarter
|
|
157
Synchrony
SYF
$23.9B
| $75.7M | 0.15% |
2,703,275
-1,500,696
| -36% | -$41.2M |
2016 Q2
1 quarter
|
|
158
Ecolab
ECL
$80.1B
| $75.3M | 0.15% |
618,508
-172,165
| -22% | -$20.8M |
2016 Q2
1 quarter
|
|
159
IBM
IBM
$228B
| $74.6M | 0.14% |
491,264
-239,548
| -33% | -$36.4M |
2016 Q2
1 quarter
|
|
160
NetEase
NTES
$80B
| $74.3M | 0.14% |
1,540,875
-109,690
| -7% | -$4.67M |
2016 Q2
1 quarter
|
|
|
PF
161
DELISTED
Pinnacle Foods, Inc.
PF
| $73.6M | 0.14% |
1,467,559
-238,670
| -14% | -$11.8M |
2016 Q2
1 quarter
|
|
162
Edison International
EIX
$21.8B
| $73M | 0.14% |
1,010,606
-20,090
| -2% | -$1.51M |
2016 Q2
1 quarter
|
|
|
163
McKesson
MCK
$119B
| $72.9M | 0.14% |
436,978
+234,751
| +116% | +$43.8M |
2016 Q2
1 quarter
|
|
164
TransDigm Group
TDG
$63.1B
| $72.8M | 0.14% |
251,628
-78,615
| -24% | -$22.1M |
2016 Q2
1 quarter
|
|
165
FedEx
FDX
$70.9B
| $72.5M | 0.14% |
415,007
-263,459
| -39% | -$43.1M |
2016 Q2
1 quarter
|
|
166
Cardinal Health
CAH
$59.2B
| $71.7M | 0.14% |
923,110
-384,552
| -29% | -$31.1M |
2016 Q2
1 quarter
|
|
167
American Express
AXP
$215B
| $71M | 0.14% |
1,109,526
-723,577
| -39% | -$46.5M |
2016 Q2
1 quarter
|
|
168
Zoetis
ZTS
$32.9B
| $70.8M | 0.14% |
1,361,664
-95,594
| -7% | -$4.84M |
2016 Q2
1 quarter
|
|
169
DELISTED
Primo Water Corporation
PRMW
| $70.3M | 0.14% |
4,933,924
-399,618
| -7% | -$6.13M |
2016 Q2
1 quarter
|
|
170
Brookfield Infrastructure Partners
BIP
$17B
| $69.7M | 0.13% |
3,342,590
-2,005,203
| -37% | -$38.5M |
2016 Q2
1 quarter
|
|
171
Essex Property Trust
ESS
$17.5B
| $69.6M | 0.13% |
312,012
-70,725
| -18% | -$16.1M |
2016 Q2
1 quarter
|
|
|
172
DELISTED
Du Pont De Nemours E I
DD
| $68.7M | 0.13% |
1,026,032
+795,488
| +345% | +$54M |
2016 Q2
1 quarter
|
|
173
Cenovus Energy
CVE
$61B
| $68.4M | 0.13% |
4,771,510
+546,015
| +13% | +$7.8M |
2016 Q2
1 quarter
|
|
174
Charter Communications
CHTR
$12.6B
| $68.2M | 0.13% |
252,732
-65,064
| -20% | -$16.4M |
2016 Q2
1 quarter
|
|
175
Morgan Stanley
MS
$283B
| $68M | 0.13% |
2,120,686
+290,513
| +16% | +$8.67M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.